Please login to the form below

Not currently logged in
Email:
Password:

National Dementia Declaration launched

The UK's National Institute for Health and Clinical Excellence has joined forces with 44 other organisations to form Dementia Action Alliance

A total of 45 organisations, including the UK's National Institute for Health and Clinical Excellence (NICE), have united to form the Dementia Action Alliance, which aims to bring about radical changes in the way society responds to dementia.

As a first step towards achieving this change, the Alliance has launched the National Dementia Declaration; a charter that spells out exactly what each Alliance member plans to do to improve the quality of life for people with dementia in England. 

Created in partnership with people with dementia and their carers, the declaration explains the challenges dementia presents to society and some of the outcomes being sought for people with dementia and their carers. 

Outcomes range from ensuring people with dementia have choice and control over decisions about their lives, to feeling a valued part of family, community and civic life.

Signatories to the declaration have published their own action plans setting out what they will do to secure these outcomes and improve the quality of life of people with dementia by 2014.

Commitments include promoting information on dementia to councils and delivery of a national project on the care of people with dementia in hospitals, adapting practice to better reflect the needs of people with dementia, increasing dementia-specific training and campaigning for a more prominent place for dementia on the policy and research agendas.

NICE's contribution to the declaration is the development of a quality standard on dementia care.

NICE's dementia quality standard sets out a vision of what high-quality care should look like for dementia patients on the NHS. It is underpinned by the joint NICE/Social Care Institute for Excellence (SCIE) clinical guideline on dementia care and appraisals on medicines relevant to the condition such as donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa).

UK care services minister, Paul Burstow, commented: "This Dementia Declaration shows tremendous commitment from across health and care services and the voluntary sector, to transform services and tackle stigma to make a difference for people with dementia and their families. Willingness to join forces to act should spur more organisations to join this movement for change."

27th October 2010

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics